Viktor Levitski

This inventor holds 13 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 8 EPO patents. Top assignees: Hoffmann-La Roche Inc., F. Hoffmann-La Roche Ag. Active years: 2019-2026.

USPTO Granted Patents = 13 (Patent Applications = 15)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 14)

Average Co-Inventor Count = 9.8

ph-index = 6

Forward Citations = 120(Granted Patents)

Company Filing History:

12 out of 5,011

Hoffmann-La Roche Inc.

patents

1 out of 180

F. Hoffmann-La Roche Ag

patents

Years Active: 2019-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12565530 - COMBINATION THERAPY WITH TARGETED 4-1BB (CD137) AGONISTS/ANTI-FAP BINDING DOMAIN AND ANTI-CEA/ANTI-CD3 BISPECIFIC ANTIBODY (2026-03-03),

2. 12441812 - Methods of treating cancer by administering tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules (2025-10-14),

3. 12391757 - Bispecific antibodies specific for PD1 and TIM3 (2025-08-19),

4. 12240911 - Bispecific antibodies specific for OX40 (2025-03-04),

5. 12202870 - Antigen binding molecules comprising a trimeric TNF family ligand and encoding polynucleotides thereof (2025-01-21),

6. 11306154 - Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer (2022-04-19),

7. 11267903 - Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer (2022-03-08),

8. 11149083 - Antigen binding molecules comprising a TNF family ligand trimer and a Tenascin binding moiety (2021-10-19),

9. 11130810 - Bispecific antibodies specific for PD1 and TIM3 (2021-09-28),

10. 10526413 - Bispecific antibodies specific for OX40 (2020-01-07),

11. 10464981 - Tumor necrosis factor (TNF) family ligand trimer-containing antigen binding molecules (2019-11-05),

12. 10392445 - Tumor necrosis factor (TNF) family ligand trimer-containing antigen-binding molecules (2019-08-27),

13. 10287352 - Bispecific antibodies specific for PD1 and TIM3 (2019-05-14),

Title: Inventor Viktor Levitski

Introduction: Viktor Levitski is a renowned inventor based in Schlieren, Switzerland, known for his groundbreaking contributions to various technological fields.

Latest Patents: Viktor Levitski holds several patents in the areas of renewable energy, nanotechnology, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Viktor Levitski has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Viktor Levitski has collaborated with top scientists, engineers, and inventors globally, fostering a culture of innovation and knowledge exchange.

Conclusion: Viktor Levitski's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.